Methotrexat-Teva onco
Methotrexat-Teva onco is a generic from Teva Pharma AG and is listed on the FOPH Specialities List. Basic health insurance reimburses it within the authorised indication. The public price ranges from CHF 25.20 to CHF 358.50 depending on the pack; the co-payment is 10 per cent.
Core data
- Authorisation holder
- Teva Pharma AG
- ATC code
- L01BA01
- IT group
- 07.16.10 Cytostatica
- Active substances
- Methotrexatum
- Preparation type
- Generic
- On the SL since
- 01/05/2006
- Last price change
- 01/03/2018
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Inj Lös 50 mg/2ml | Durchstf 2 ml | CHF 8.06 | CHF 25.20 | 01/06/2017 | A | 7680479990014 |
| Inj Lös 500 mg/20ml | 20 ml | CHF 52.47 | CHF 73.50 | 01/04/2017 | A | 7680479990021 |
| Inj Lös 5000 mg/50ml | 50 ml | CHF 314.54 | CHF 358.50 | 01/02/2017 | A | 7680479990045 |
Limitation
No limitation is recorded on the SL for this preparation.
FAQ
Is Methotrexat-Teva onco covered by Swiss health insurance?
Yes. Methotrexat-Teva onco is on the FOPH Specialities List, so Swiss mandatory health insurance reimburses it within the authorised indication. You still pay the deductible and a co-payment of 10 per cent.
What does Methotrexat-Teva onco cost in Switzerland?
The public price is the maximum price set by the FOPH and for Methotrexat-Teva onco ranges from CHF 25.20 to CHF 358.50 per pack. The ex-factory price ranges from CHF 8.06 to CHF 314.54. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages